申请人:Yamanouchi Pharmaceutical Co., Ltd.
公开号:US06245796B1
公开(公告)日:2001-06-12
A tricyclic pyrrole or pyrazole derivative represented by the following general formula (I), or a pharmaceutically acceptable salt thereof, which shows strong affinity and selectivity for the 5-HT2C receptor and is useful for the treatment of central nervous system diseases such as sexual disorders, eating disorders, anxiety, depression and sleeping disorders.
(In the above formula, each symbol means as follows;
Y ring: an unsaturated five-membered ring which may have 1 to 3 of one or more types of hetero atom(s) each selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom or an unsaturated six-membered ring having 1 or 2 nitrogen atom(s),
X: a bond or a carbon atom,
a double bond or a single bond,
V: a nitrogen atom or a group represented by a formula CH, and
A: a straight or branched lower alkylene group which may be substituted with a halogen atom or a cycloalkyl group).
以下是通用公式(I)所代表的三环吡咯或吡唑衍生物,或其药学上可接受的盐,该衍生物对5-HT2C受体具有强亲和力和选择性,并可用于治疗中枢神经系统疾病,如性功能障碍、进食障碍、焦虑、抑郁和睡眠障碍。(在上述公式中,每个符号的含义如下:Y环:一种不饱和的五元环,可能含有1至3个来自氮原子、氧原子和硫原子中的一种或多种异原子,或含有1或2个氮原子的不饱和六元环,X:一种键或一个碳原子,双键或单键,V:一个氮原子或一个由CH公式表示的基团,A:一种直链或支链低碳烷基基团,可能被卤原子或环烷基基团取代)。